Figure 2
From: Pitavastatin in cardiometabolic disease: therapeutic profile
Pitavastatin presents high-density lipoprotein-cholesterol-elevating efficacy that increases with time. Pitavastatin has significant high-density lipoprotein-cholesterol (HDL-C)-elevating efficacy – especially in patients with low baseline HDL-C – that continues to increase over time (LIVES HDL substudy). Values are mean ± standard deviation. ANOVA, analysis of variance. Adapted from [46].